幹細胞治療の市場規模、シェア、成長分析：細胞源別、タイプ別、治療用途別、地域別 - 産業予測 2025～2032年

幹細胞治療の世界市場規模は2023年に123億米ドルとなり、予測期間（2025-2032年）のCAGRは14.3%で、2024年の140億6,000万米ドルから2032年には409億6,000万米ドルに成長する見通しです。

世界の幹細胞治療市場は、がんなどの疾患の有病率の増加や再生医療の進歩に牽引され、大きな成長を遂げています。幹細胞は、治癒や組織再生を助ける特殊な細胞を開発するための万能な供給源として機能し、幹細胞治療を従来の臓器移植に代わる実行可能な選択肢として位置づけています。研究者は、心筋や血液細胞のような特定の細胞を作り出すために幹細胞を革新的に培養・改変し、治療の選択肢を増やしています。さらに、成体組織から誘導された人工多能性幹細胞の可能性が市場を支えており、治療における新たな道が期待されています。加えて、幹細胞移植のような、損傷した細胞と入れ替わる治療法は、血液関連疾患や悪性腫瘍の治療方法を大きく変えつつあり、市場の大きな可能性を浮き彫りにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 特許分析
• 技術分析
• ケーススタディ

幹細胞治療市場規模：細胞源別 & CAGR（2025-2032）

• 市場概要
• 脂肪組織由来間葉系幹細胞
• 骨髄由来間葉系幹細胞
• 胎盤/臍帯由来間葉系幹細胞
• その他

幹細胞治療市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 同種異系幹細胞治療
• 自家幹細胞治療

幹細胞治療市場規模：治療用途別& CAGR（2025-2032）

• 市場概要
• 筋骨格障害
• 傷と手術
• 炎症性疾患と自己免疫疾患
• 再生医療
• 医薬品の発見と開発
• 心血管疾患
• 神経疾患
• その他

幹細胞治療市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Novartis AG（Switzerland）
• Pfizer Inc.（US）
• Mesoblast Limited（Australia）
• Gamida Cell Ltd.（Israel）
• Vericel Corporation（US）
• Medipost Co., Ltd.（South Korea）
• Astellas Pharma Inc.（Japan）
• Cynata Therapeutics Limited（Australia）
• Lonza Group Ltd.（Switzerland）
• Caladrius Biosciences, Inc.（US）
• Athersys, Inc.（US）
• Cytori Therapeutics, Inc.（US）
• Holostem Terapie Avanzate S.r.l.（Italy）
• Pluristem Therapeutics Inc.（Israel）
• BioTime, Inc.（US）
• Smith+Nephew（UK）
• JCR Pharmaceuticals Co., Ltd.（Japan）
• Anterogen Co., Ltd.（South Korea）
• Corestem, Inc.（South Korea）
• Pharmicell Co., Ltd（South Korea）

結論と提言

Global Stem Cell Therapy Market size was valued at USD 12.3 billion in 2023 and is poised to grow from USD 14.06 billion in 2024 to USD 40.96 billion by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).

The global stem cell therapy market is witnessing significant growth, driven by the increasing prevalence of diseases such as cancer and advancements in regenerative medicine. Stem cells serve as a versatile source for developing specialized cells to aid in healing and tissue regeneration, positioning stem cell therapy as a viable alternative to traditional organ transplantation. Researchers are innovatively cultivating and modifying stem cells to create specific cell types, such as heart muscle or blood cells, enhancing treatment options. The market is further supported by the potential of induced pluripotent stem cells derived from adult tissue, promising new avenues in therapy. Additionally, procedures like stem cell transplants, which replace damaged cells, are transforming how blood-related disorders and malignancies are treated, highlighting immense market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Therapy Market Segments Analysis

Global Stem Cell Therapy Market is segmented by Cell Source, Type, Therapeutic Application and region. Based on Cell Source, the market is segmented into Adipose Tissue-derived Mesenchymal Stem Cells, Bone Marrow-derived Mesenchymal Stem Cells, Placenta/Umbilical Cord-derived Mesenchymal Stem Cells and Other. Based on Type, the market is segmented into Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy. Based on Therapeutic Application, the market is segmented into Musculoskeletal Disorders, Wounds & Surgeries, Inflammatory & Autoimmune Diseases, Regenerative Medicine, Drug Discovery and Development, Cardiovascular Diseases, Neurological Disorders and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is significantly driven by financial support from government agencies and favorable regulatory frameworks that create a supportive environment for research and development in this field. The growing demand for innovative and effective treatment alternatives for autoimmune, neurological, and cardiovascular disorders has led to heightened research initiatives and increased funding for cell-based studies. This emphasis on advancing therapeutic solutions fosters a robust landscape for stem cell research, ultimately enhancing the potential for breakthroughs and improvements in patient care, thus propelling the expansion of the stem cell therapy market on a global scale.

Restraints in the Global Stem Cell Therapy Market

The global stem cell therapy market faces significant challenges primarily due to ethical concerns surrounding the use of embryonic stem cells. These cells are predominantly sourced from human embryos, raising moral issues related to the potential destruction of human life. This ethical dilemma complicates the commercial development of stem cell treatments. Furthermore, the landscape for stem cell research and applications is inconsistent across different regions, influenced by varying regulations and public perceptions. As a result, these factors create a complex environment that hinders advancements and acceptance within the stem cell therapy market.

Market Trends of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is witnessing significant growth and transformation, driven by advancements in therapeutic innovations and increased demand for regenerative medicine. Pharmaceutical companies are actively seeking specialized talent with expertise in stem cell research and product development, reflecting a shift towards more complex therapeutic applications. As they explore novel drug delivery systems and expand their product portfolios, collaboration with firms possessing deep knowledge in biological sciences and controlled release methodologies has become paramount. This trend highlights the burgeoning intersection of research and commercialization in stem cell therapies, paving the way for breakthrough treatments and improved patient outcomes in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Technology Analysis
• Case Studies

Global Stem Cell Therapy Market Size by Cell Source & CAGR (2025-2032)

• Market Overview
• Adipose Tissue-derived Mesenchymal Stem Cells
• Bone Marrow-derived Mesenchymal Stem Cells
• Placenta/Umbilical Cord-derived Mesenchymal Stem Cells
• Other

Global Stem Cell Therapy Market Size by Type & CAGR (2025-2032)

• Market Overview
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy

Global Stem Cell Therapy Market Size by Therapeutic Application & CAGR (2025-2032)

• Market Overview
• Musculoskeletal Disorders
• Wounds & Surgeries
• Inflammatory & Autoimmune Diseases
• Regenerative Medicine
• Drug Discovery and Development
• Cardiovascular Diseases
• Neurological Disorders
• Other

Global Stem Cell Therapy Market Size & CAGR (2025-2032)

• North America (Cell Source, Type, Therapeutic Application)
  • US
  • Canada
• Europe (Cell Source, Type, Therapeutic Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Cell Source, Type, Therapeutic Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Cell Source, Type, Therapeutic Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Cell Source, Type, Therapeutic Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gamida Cell Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medipost Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynata Therapeutics Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caladrius Biosciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athersys, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytori Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Holostem Terapie Avanzate S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pluristem Therapeutics Inc. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTime, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith+Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JCR Pharmaceuticals Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anterogen Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corestem, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmicell Co., Ltd (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations